Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Looking Into Novartis's Recent Short Interest
Novartis Ends Development of Phase 2 Idiopathic Pulmonary Fibrosis Asset
Eight Stocks Positioned for Short Sales – Oppenheimer Asset Management
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
Exelixis And Merck Sign Clinical Development Collaboration To Evaluate Investigational Zanzalintinib In Combination With KEYTRUDA In Head And Neck Cancer And In Combination With WELIREG In Renal Cell Carcinoma
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
loading...
70133785 : Meaningless suggestion! No one is trading pharmaceutical stocks! Technology is needed to boost the economy.
Deep Sea 70133785 : Tech stocks are overvalued and overhyped. They will start correction when the time comes. Risk is high to trade them, I would rather buy value stock with high dividend yield
Deep Sea : 16 October, starboard going to meet Pfizer ceo. Let’s see how they are going to revive the company’s fortune.
103362512 Deep Sea :